The Neonatal Therapeutic Intervention Scoring System (NTISS) can be used to assess the severity of illness for a neonate in the Intensive Care Unit (ICU). The NTISS on the day of admission to the ICU correlates with length of stay, total hospital charges and resource utilization.
|
Parameter |
Item |
Subscore |
|---|---|---|
|
respiratory |
supplemental oxygen [1] |
1 |
|
|
surfactant administration |
1 |
|
|
tracheostomy care [2] |
1 |
|
|
tracheostomy placement [2] |
1 |
|
|
continuous positive airway pressure administration [1] |
2 |
|
|
endotracheal intubation |
2 |
|
|
mechanical ventilation [1] |
3 |
|
|
mechanical ventilation with muscle relaxation [1] |
4 |
|
|
high-frequency ventilation [1] |
4 |
|
|
extracorporeal membrane oxygenation |
4 |
|
cardiovascular |
indomethacin administration |
1 |
|
|
volume expansion (<= 15 mL/kg) [3] |
1 |
|
|
vasopressor administration (1 agent) [4] |
2 |
|
|
volume expansion (> 15 mL/kg) [3] |
3 |
|
|
vasopressor administration (> 1 agent) [4] |
3 |
|
|
pacemaker on standby [5] |
3 |
|
|
pacemaker used [5] |
4 |
|
|
cardiopulmonary resuscitation |
4 |
|
drug therapy |
antibiotic administration (<= 2 agents) [6] |
1 |
|
|
diuretic administration (enteral) [7] |
1 |
|
|
steroid administration (postnatal) |
1 |
|
|
anticonvulsant administration |
1 |
|
|
aminophylline administration |
1 |
|
|
other unscheduled medication |
1 |
|
|
antibiotic administration (> 2 agents) [6] |
2 |
|
|
diuretic administration (parenteral) [7] |
2 |
|
|
treatment of metabolic acidosis |
3 |
|
|
potassium binding resin administration |
3 |
|
monitoring |
frequent vital signs |
1 |
|
|
cardiorespiratory monitoring |
1 |
|
|
phlebotomy (5-10 blood draws) [8] |
1 |
|
|
thermoregulated environment |
1 |
|
|
noninvasive oxygen monitoring |
1 |
|
|
arterial pressure monitoring |
1 |
|
|
central venous pressure monitoring |
1 |
|
|
urinary catheters |
1 |
|
|
quantitative intake and output |
1 |
|
|
extensive phlebotomy (> 10 blood draws) [8] |
2 |
|
metabolic/nutrition |
gavage feeding |
1 |
|
|
intravenous fat emulsion |
1 |
|
|
intravenous amino acid solution |
1 |
|
|
phototherapy |
1 |
|
|
insulin administration |
2 |
|
|
potassium infusion |
3 |
|
transfusion |
intravenous gamma globulin |
1 |
|
|
red blood cell transfusion (<= 15 mL/kg) [9] |
2 |
|
|
partial volume exchange transfusion |
2 |
|
|
red blood cell transfusion (> 15 mL/kg) [9] |
3 |
|
|
platelet transfusion |
3 |
|
|
white blood cell transfusion |
3 |
|
|
double volume exchange transfusion |
3 |
|
procedural |
transport of patient |
2 |
|
|
single chest tube in place [11] |
2 |
|
|
minor operation [12] |
2 |
|
|
multiple chest tubes in place [11] |
3 |
|
|
thoracentesis |
3 |
|
|
major operation [12] |
4 |
|
|
pericardiocentesis [13] |
4 |
|
|
pericardial tube in place [13] |
4 |
|
|
dialysis |
4 |
|
vascular access |
peripheral intravenous line |
1 |
|
|
arterial line |
2 |
|
|
central venous line |
2 |
where:
• items in brackets ("[ ]") are mutually exclusive
• partial and double volume exchange transfusions are not listed as mutually exclusive
• endotracheal intubation and tracheostomy use are not listed as mutually exclusive
• potassium infusion and binding resin administration are not listed as mutually exclusive
NTISS =
=SUM(applicable subscores)
Interpretation:
• minimum score: 0
• maximum score: 100
|
NTISS |
Estimated Risk |
Mortality (in 1992) |
|---|---|---|
|
0 - 9 |
low |
1% |
|
10 - 19 |
mild-to-moderate |
4-5% |
|
20 - 29 |
moderate |
18-19% |
|
>= 30 |
high |
20-30% |
(after Figure 2, page 564)
Specialty: Critical Care, Emergency Medicine
